Literature DB >> 7700359

Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene.

R Zhang1, F W Alt, L Davidson, S H Orkin, W Swat.   

Abstract

The product of the vav proto-oncogene, p95vav or Vav, is tyrosine phosphorylated upon stimulation of T and B cells by antigen and other receptors, and contains motifs associated with signal transduction. To determine its role in vivo, we used vav-gene-targeted embryonic stem cells and RAG-2-/- blastocyst complementation. The vav(-/-)-RAG-2-/- chimaeras displayed thymic atrophy with reduced numbers of peripheral T cells. Whereas the total number of B cells was normal, the subset of peritoneal B-1 (CD5+) cells was missing. The vav-/- T and B cells were hyporeactive when stimulated through antigen receptors, but vav-/- T cells proliferated on exposure to phorbol ester and calcium ionophore, whereas B cells responded normally to bacterial mitogen, lipopolysaccharide or the CD40 ligand. Thus, we have established here a functional role for vav in the control of T- and B-cell development and activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700359     DOI: 10.1038/374470a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

Review 2.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.

Authors:  P S Costello; A E Walters; P J Mee; M Turner; L F Reynolds; A Prisco; N Sarner; R Zamoyska; V L Tybulewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Vav3 is regulated during the cell cycle and effects cell division.

Authors:  Keiko Fujikawa; Yoshiro Inoue; Masaharu Sakai; Yoshikazu Koyama; Shinzo Nishi; Ryo Funada; Frederick W Alt; Wojciech Swat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

5.  Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.

Authors:  T S Manetz; C Gonzalez-Espinosa; R Arudchandran; S Xirasagar; V Tybulewicz; J Rivera
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 6.  Role of CD19 signal transduction in B cell biology.

Authors:  Robert H Carter; Yue Wang; Stephen Brooks
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  Vav family proteins couple to diverse cell surface receptors.

Authors:  S L Moores; L M Selfors; J Fredericks; T Breit; K Fujikawa; F W Alt; J S Brugge; W Swat
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Generation and analysis of Siah2 mutant mice.

Authors:  Ian J Frew; Vicki E Hammond; Ross A Dickins; Julian M W Quinn; Carl R Walkley; Natalie A Sims; Ralf Schnall; Neil G Della; Andrew J Holloway; Matthew R Digby; Peter W Janes; David M Tarlinton; Louise E Purton; Matthew T Gillespie; David D L Bowtell
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration.

Authors:  Fabiola V Rivas; James P O'Keefe; Maria-Luisa Alegre; Thomas F Gajewski
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex.

Authors:  Shiann-Tarng Jou; Nick Carpino; Yutaka Takahashi; Roland Piekorz; Jyh-Rong Chao; Neena Carpino; Demin Wang; James N Ihle
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.